Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Gansbacher

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Gene Medicine|April 1, 2003
Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT)Bernd Gansbacher,
Human Gene Therapy|July 9, 2010
Prostate cancer gene therapy: attempts to innovateStefan Kochanek, Bernd Gansbacher
Human Gene Therapy|October 24, 2009
Cancer gene therapy: present and futureChiara Bonini, Bernd Gansbacher
Cancer Research|October 6, 2005
Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the hostCharlotte Kopitz, Martina Anton, Bernd Gansbacher, et al.
Human Gene Therapy|August 7, 2008
Plasminogen activator inhibitor-2, but not cystatin C, inhibits the prometastatic activity of tissue inhibitor of metalloproteinases-1 in the liverCharlotte Kopitz, Michael Gerg, Bernd Gansbacher, et al.
German Medical Science : GMS E-Journal|October 21, 2017
A comparison of medical education in Germany and the United States: from applying to medical school to the beginnings of residencyDmitry Zavlin, Kevin T Jubbal, Jonas G Noé, et al.
Pharmaceutical Research|December 31, 2011
Optimizing adenoviral transduction of endothelial cells under flow conditionsMartina Anton, Anja Wolf, Olga Mykhaylyk, et al.
Cancer Gene Therapy|April 2, 2005
Optimization of radiation controlled gene expression by adenoviral vectors in vitroMartina Anton, Iman E O Gomaa, Tobias von Lukowicz, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 26, 2008
Searching for the right timing of surgical delay: angiogenesis, vascular endothelial growth factor and perfusion changes in a skin-flap modelThomas Holzbach, Iva Neshkova, Dialekti Vlaskou, et al.
Arthritis and Rheumatism|March 24, 2010
Tetracycline-regulated bone morphogenetic protein 2 gene expression in lentivirally transduced primary rabbit chondrocytes for treatment of cartilage defectsDaniela Wübbenhorst, Katja Dumler, Bettina Wagner, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Gene Medicine|April 1, 2003
Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT)Bernd Gansbacher,
Human Gene Therapy|July 9, 2010
Prostate cancer gene therapy: attempts to innovateStefan Kochanek, Bernd Gansbacher
Human Gene Therapy|October 24, 2009
Cancer gene therapy: present and futureChiara Bonini, Bernd Gansbacher
Cancer Research|October 6, 2005
Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the hostCharlotte Kopitz, Martina Anton, Bernd Gansbacher, et al.
Human Gene Therapy|August 7, 2008
Plasminogen activator inhibitor-2, but not cystatin C, inhibits the prometastatic activity of tissue inhibitor of metalloproteinases-1 in the liverCharlotte Kopitz, Michael Gerg, Bernd Gansbacher, et al.
German Medical Science : GMS E-Journal|October 21, 2017
A comparison of medical education in Germany and the United States: from applying to medical school to the beginnings of residencyDmitry Zavlin, Kevin T Jubbal, Jonas G Noé, et al.
Pharmaceutical Research|December 31, 2011
Optimizing adenoviral transduction of endothelial cells under flow conditionsMartina Anton, Anja Wolf, Olga Mykhaylyk, et al.
Cancer Gene Therapy|April 2, 2005
Optimization of radiation controlled gene expression by adenoviral vectors in vitroMartina Anton, Iman E O Gomaa, Tobias von Lukowicz, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 26, 2008
Searching for the right timing of surgical delay: angiogenesis, vascular endothelial growth factor and perfusion changes in a skin-flap modelThomas Holzbach, Iva Neshkova, Dialekti Vlaskou, et al.
Arthritis and Rheumatism|March 24, 2010
Tetracycline-regulated bone morphogenetic protein 2 gene expression in lentivirally transduced primary rabbit chondrocytes for treatment of cartilage defectsDaniela Wübbenhorst, Katja Dumler, Bettina Wagner, et al.
Pageof 4